Christine A. Poon

CIK: 0001189014

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (11.5%)

Position reduction

Option Exercises (M)6 (11.5%)

Derivative conversions

Awards (A)37 (71.2%)

Compensation grants

Other (G, F, J, C, D, …)3 (5.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

PRU

PRUDENTIAL FINANCIAL INC

Director

NBIX

NEUROCRINE BIOSCIENCES INC

Director

REGN

REGENERON PHARMACEUTICALS, INC.

Director

SHW

SHERWIN WILLIAMS CO

Director

Discretionary Trading P&L

Holdings

Transaction History (52 total)

PRU
PRUDENTIAL FINANCIAL INC
Sep 10, 2026
Award(A)
2026 Restricted Stock Units
Direct
21 shares at avg. $118.48-
PRU
PRUDENTIAL FINANCIAL INC
Sep 10, 2026
Award(A)
Notional Shares - Optional
Direct
49 shares at avg. $118.48-
PRU
PRUDENTIAL FINANCIAL INC
Sep 10, 2026
Award(A)
Notional Shares - Mandatory
Direct
161 shares at avg. $118.48-
PRU
PRUDENTIAL FINANCIAL INC
Jun 11, 2026
Award(A)
Notional Shares - Optional
Direct
54 shares at avg. $106.51-
PRU
PRUDENTIAL FINANCIAL INC
Jun 11, 2026
Award(A)
2026 Restricted Stock Units
Direct
23 shares at avg. $106.51-
PRU
PRUDENTIAL FINANCIAL INC
Jun 11, 2026
Award(A)
Notional Shares - Mandatory
Direct
177 shares at avg. $106.51-
NBIX
NEUROCRINE BIOSCIENCES INC
May 27, 2026
Award(A)
Restriced Stock Unit
Direct
2.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
May 21, 2026
Exercise(M)
Direct
3.3K shares-
PRU
PRUDENTIAL FINANCIAL INC
May 12, 2026
Award(A)
2026 Restricted Stock Units
Direct
1.8K shares-
PRU
PRUDENTIAL FINANCIAL INC
May 12, 2026
Disposition(D)
Direct
1.8K shares at avg. $102.58$181K
PRU
PRUDENTIAL FINANCIAL INC
May 12, 2026
Exercise(M)
Direct
1.8K shares-
PRU
PRUDENTIAL FINANCIAL INC
Mar 12, 2026
Award(A)
2025 Restricted Stock Units
Direct
26 shares at avg. $92.34-
PRU
PRUDENTIAL FINANCIAL INC
Mar 12, 2026
Award(A)
Notional Shares - Mandatory
Direct
201 shares at avg. $92.34-
PRU
PRUDENTIAL FINANCIAL INC
Mar 12, 2026
Award(A)
Notional Shares - Optional
Direct
61 shares at avg. $92.34-
REGN
REGENERON PHARMACEUTICALS, INC.
Jan 2, 2026
Award(A)
Direct
155 shares-
PRU
PRUDENTIAL FINANCIAL INC
Dec 11, 2025
Award(A)
2025 Restricted Stock Units
Direct
19 shares at avg. $117.05-
PRU
PRUDENTIAL FINANCIAL INC
Dec 11, 2025
Award(A)
Notional Shares - Optional
Direct
46 shares at avg. $117.05-
PRU
PRUDENTIAL FINANCIAL INC
Dec 11, 2025
Award(A)
Notional Shares - Mandatory
Direct
151 shares at avg. $117.05-
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 30, 2025
Exercise(M)
Direct
2.7K shares at avg. $520.01$1.4M
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 29, 2025
Sale(S)
Direct
388 shares at avg. $657.29$255K
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 29, 2025
Sale(S)
Direct
2.7K shares at avg. $653.50$1.8M
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 29, 2025
Sale(S)
Direct
712 shares at avg. $656.50$467K
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 29, 2025
Sale(S)
Direct
650 shares at avg. $652.68$424K
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 29, 2025
Exercise(M)
Direct
6.5K shares at avg. $520.01$3.4M
REGN
REGENERON PHARMACEUTICALS, INC.
Oct 29, 2025
Sale(S)
Direct
100 shares at avg. $655.10$66K

		Type	Shares	Price		Ownership
Sep 10, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) 2026 Restricted Stock Units	21	$118.48	-	Direct
Sep 10, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Optional	49	$118.48	-	Direct
Sep 10, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Mandatory	161	$118.48	-	Direct
Jun 11, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Optional	54	$106.51	-	Direct
Jun 11, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) 2026 Restricted Stock Units	23	$106.51	-	Direct
Jun 11, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Mandatory	177	$106.51	-	Direct
May 27, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Restriced Stock Unit	2,567	-	-	Direct
May 21, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	3,318	-	$0	Direct
May 12, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) 2026 Restricted Stock Units	1,754	-	-	Direct
May 12, 2026	PRU PRUDENTIAL FINANCIAL INC	Disposition(D)	1,765	$102.58	$181,054	Direct
May 12, 2026	PRU PRUDENTIAL FINANCIAL INC	Exercise(M)	1,765	-	$0	Direct
Mar 12, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) 2025 Restricted Stock Units	26	$92.34	-	Direct
Mar 12, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Mandatory	201	$92.34	-	Direct
Mar 12, 2026	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Optional	61	$92.34	-	Direct
Jan 2, 2026	REGN REGENERON PHARMACEUTICALS, INC.	Award(A)	155	-	$0	Direct
Dec 11, 2025	PRU PRUDENTIAL FINANCIAL INC	Award(A) 2025 Restricted Stock Units	19	$117.05	-	Direct
Dec 11, 2025	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Optional	46	$117.05	-	Direct
Dec 11, 2025	PRU PRUDENTIAL FINANCIAL INC	Award(A) Notional Shares - Mandatory	151	$117.05	-	Direct
Oct 30, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Exercise(M)	2,712	$520.01	$1,410,267	Direct
Oct 29, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Sale(S)	388	$657.29	$255,029	Direct
Oct 29, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Sale(S)	2,735	$653.50	$1,787,323	Direct
Oct 29, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Sale(S)	712	$656.50	$467,428	Direct
Oct 29, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Sale(S)	650	$652.68	$424,242	Direct
Oct 29, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Exercise(M)	6,500	$520.01	$3,380,065	Direct
Oct 29, 2025	REGN REGENERON PHARMACEUTICALS, INC.	Sale(S)	100	$655.10	$65,510	Direct

1-25 of 52 transactions

About POON CHRISTINE A

POON CHRISTINE A (SEC CIK 0001189014) files insider reports with the SEC as Director of PRUDENTIAL FINANCIAL INC (PRU), Director of NEUROCRINE BIOSCIENCES INC (NBIX) and Director of REGENERON PHARMACEUTICALS, INC. (REGN). Signal8 also holds filings tied to 1 other company.

Signal8 holds 21 ownership filings by POON CHRISTINE A, all Form 4s, filed between Sep 16, 2024 and Sep 14, 2026. Those filings report 52 transactions, from Sep 12, 2024 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on POON CHRISTINE A's filings is in NEWARK, NJ.

Recent filings by POON CHRISTINE A

Sep 10, 2026: Grants or awards of PRU derivative securities (3 lines, Form 4, code A).
Jun 11, 2026: Grants or awards of PRU derivative securities (3 lines, Form 4, code A).
May 27, 2026: Grant or award of NBIX derivative securities (Form 4, code A).
May 21, 2026: Option exercise of NBIX shares (Form 4, code M).
May 12, 2026: Grant or award of PRU derivative securities (Form 4, code A).

Other insiders filing for PRUDENTIAL FINANCIAL INC (PRU)

Waldeck George P Jr., Executive Vice President
SULLIVAN ANDREW F, Chief Executive Officer
Wolk Joseph J, Director
TODMAN MICHAEL, Director
Stoddard Thomas D, Director
Pianalto Sandra, Director

How to read Form 4 transaction codes